The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 07, 2019
Filed:
Aug. 28, 2015
Applicants:
Medizinische Universität Wien, Vienna, AT;
Universität Wien, Vienna, AT;
Inventors:
Katrina Vanura, Vienna, AT;
Ulrich Jäger, Vienna, AT;
Thomas Erker, Vienna, AT;
Gerda Brunhofer-Bolzer, Vienna, AT;
Assignees:
Medizinische Universität Wien, Vienna, AT;
Universität Wien, Vienna, AT;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 209/10 (2006.01); C07D 307/80 (2006.01); C07D 317/08 (2006.01); C07D 333/56 (2006.01); C07D 409/04 (2006.01); C07C 49/255 (2006.01); C07C 49/577 (2006.01); A61K 31/404 (2006.01); A61P 35/00 (2006.01); A61K 31/381 (2006.01); A61K 31/423 (2006.01); A61K 31/4184 (2006.01); A61K 31/343 (2006.01); A61K 31/416 (2006.01); A61K 31/33 (2006.01); C07C 49/20 (2006.01);
U.S. Cl.
CPC ...
C07D 409/04 (2013.01); A61K 31/33 (2013.01); A61K 31/343 (2013.01); A61K 31/381 (2013.01); A61K 31/404 (2013.01); A61K 31/416 (2013.01); A61K 31/4184 (2013.01); A61K 31/423 (2013.01); A61P 35/00 (2018.01); C07C 49/20 (2013.01); C07D 209/10 (2013.01); C07D 307/80 (2013.01); C07D 317/08 (2013.01); C07D 333/56 (2013.01);
Abstract
The present invention relates to heteroaromatic chalcone derivatives, particularly the compounds of formula (I) as described and defined herein, pharmaceutical compositions comprising these compounds, and their medical use, including their use in the treatment or prevention of cancer and, in particular, in the treatment or prevention of hematologic malignancies.